Sorafenib (BAY 43-9006): Review of Clinical Development

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|1|3|223-228

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.1, Iss.3, 2006-01, pp. : 223-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development

By  

Current Medicinal Chemistry, Vol. 19, Iss. 7, 2012-03 ,pp. : 938-944

Bentham Science Publishers

Access to resources Recommend Favorite

BAY 43-9006: Early Clinical Data in Patients with Advanced Solid Malignancies

By  

Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. : 2249-2253

Bentham Science Publishers

Access to resources Recommend Favorite

BAY 43-9006: Preclinical Data

By  

Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. : 2255-2257

Bentham Science Publishers

Access to resources Recommend Favorite

Sorafenib: a clinical and pharmacologic review

By Iyer Renuka   Fetterly Gerald   Lugade Amit   Thanavala Yasmin  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 11, 2010-08 ,pp. : 1943-1955

Informa Healthcare

Access to resources Recommend Favorite

Toxicity of sorafenib: clinical and molecular aspects

By Blanchet Benoit   Billemont Bertrand   Barete Stéphane   Garrigue Hélène   Cabanes Laure   Coriat Romain   Francès Camille   Knebelmann Bertrand   Goldwasser François  

Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. : 275-287

Informa Healthcare

Access to resources Recommend Favorite